US biosimilar norms to keep local drug cos in good health
Published on: Oct. 31, 2025, 12:46 a.m. | Source: The Economic Times
With the new regulations set by the US FDA, the pathway to creating biosimilars will be both faster and more cost-effective. This development is a game changer for Indian firms like Biocon and Dr Reddy's Laboratories, allowing them to provide more economical medicines to patients.
